Aigen Investment Management LP acquired a new position in shares of Globe Life Inc. (NYSE:GL - Free Report) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 7,080 shares of the company's stock, valued at approximately $750,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Empowered Funds LLC boosted its holdings in Globe Life by 22.5% during the first quarter. Empowered Funds LLC now owns 7,327 shares of the company's stock worth $853,000 after buying an additional 1,346 shares in the last quarter. QRG Capital Management Inc. grew its position in Globe Life by 69.7% during the 1st quarter. QRG Capital Management Inc. now owns 2,867 shares of the company's stock worth $334,000 after purchasing an additional 1,178 shares in the last quarter. ProShare Advisors LLC lifted its holdings in shares of Globe Life by 2.3% in the first quarter. ProShare Advisors LLC now owns 18,096 shares of the company's stock valued at $2,106,000 after purchasing an additional 413 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its position in Globe Life by 35.3% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 193,173 shares of the company's stock valued at $22,480,000 after buying an additional 50,409 shares during the period. Finally, State Board of Administration of Florida Retirement System boosted its position in Globe Life by 12.2% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 114,353 shares of the company's stock worth $12,581,000 after acquiring an additional 12,449 shares during the period. Institutional investors and hedge funds own 81.61% of the company's stock.
Globe Life Stock Down 1.2 %
Globe Life stock traded down $1.28 during midday trading on Thursday, reaching $108.79. The stock had a trading volume of 197,503 shares, compared to its average volume of 1,532,704. The stock has a market capitalization of $9.13 billion, a P/E ratio of 9.31 and a beta of 0.81. The firm's fifty day simple moving average is $106.75 and its 200-day simple moving average is $94.26. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.00.
Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.06 by $0.43. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.46 billion. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. The business's quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.71 EPS. As a group, analysts expect that Globe Life Inc. will post 12.32 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of research analysts recently commented on GL shares. Wells Fargo & Company boosted their price objective on shares of Globe Life from $108.00 to $117.00 and gave the company an "overweight" rating in a research report on Thursday, October 10th. TD Cowen initiated coverage on Globe Life in a report on Wednesday, October 9th. They issued a "buy" rating and a $150.00 price objective on the stock. Morgan Stanley raised their price target on shares of Globe Life from $110.00 to $120.00 and gave the company an "equal weight" rating in a report on Thursday, October 24th. Keefe, Bruyette & Woods boosted their price target on Globe Life from $120.00 to $125.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 29th. Finally, Piper Sandler increased their price target on Globe Life from $118.00 to $130.00 and gave the company an "overweight" rating in a report on Friday, October 25th. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $124.50.
View Our Latest Research Report on Globe Life
Globe Life Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Read More
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.